Variant report
Variant | nsv574433 |
---|---|
Chromosome Location | chr17:15034841-15058236 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:15050928..15053562-chr17:15069827..15072655,2 | K562 | blood: | |
2 | chr17:15030801..15032445-chr17:15040357..15042858,2 | K562 | blood: | |
3 | chr17:15034854..15037130-chr17:15046281..15047944,2 | K562 | blood: | |
4 | chr17:14829340..14831544-chr17:15056657..15059444,2 | MCF-7 | breast: | |
5 | chr17:15034854..15037130-chr17:15046281..15047944,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs917538 | chr17:15034841-15034842 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs917539 | chr17:15034864-15034865 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs192147957 | chr17:15034883-15034884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575160956 | chr17:15034890-15034891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114599997 | chr17:15034917-15034918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557772858 | chr17:15034927-15034928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs62072212 | chr17:15034948-15034949 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs539865302 | chr17:15034955-15034956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560120333 | chr17:15034957-15034958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528938078 | chr17:15034973-15034974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140201884 | chr17:15034978-15034979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562737460 | chr17:15034987-15034988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531790742 | chr17:15034994-15034995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs117501215 | chr17:15035021-15035022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112329822 | chr17:15035050-15035051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149824356 | chr17:15035059-15035060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570188588 | chr17:15035102-15035103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112497011 | chr17:15035130-15035131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547455009 | chr17:15035135-15035136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1076385 | chr17:15035143-15035144 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs536735032 | chr17:15035145-15035146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550344543 | chr17:15035185-15035186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs145789285 | chr17:15035258-15035259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571540528 | chr17:15035282-15035283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs56008586 | chr17:15035327-15035328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs74405006 | chr17:15035426-15035427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148983793 | chr17:15035441-15035442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143061667 | chr17:15035513-15035514 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553477661 | chr17:15035540-15035541 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73980992 | chr17:15035558-15035559 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs34744997 | chr17:15035560-15035561 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147804221 | chr17:15035570-15035571 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562253017 | chr17:15035573-15035574 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs141102634 | chr17:15035623-15035624 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs563074661 | chr17:15035661-15035662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77915431 | chr17:15035664-15035665 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73281228 | chr17:15035683-15035684 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs527964174 | chr17:15035684-15035685 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548109488 | chr17:15035744-15035745 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs536096217 | chr17:15035745-15035746 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186885688 | chr17:15035758-15035759 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146940733 | chr17:15035813-15035814 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs75760449 | chr17:15035818-15035819 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2079749 | chr17:15035833-15035834 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs138198558 | chr17:15035835-15035836 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2323561 | chr17:15035838-15035839 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs7213398 | chr17:15035846-15035847 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs74323712 | chr17:15035901-15035902 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553651002 | chr17:15035905-15035906 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558696569 | chr17:15035934-15035935 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21509527 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Autism | 17322880 | CNVD |
Hereditary neuropathy with liability to pressure palsy | 19521722 | CNVD |
Schizophrenia | 19571808 | CNVD |
Schizophrenia | 19955444 | CNVD |
Charcot-marie-tooth disease | 18787571 | CNVD |
Breast cancer | 20409316 | CNVD |
Autism | 18414403 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Peripheral neuropathy | 21193943 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 22958593 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Breast cancer | 21858162 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 20967226 | CNVD |
Autism | 18522746 | CNVD |
Epilepsy | 21635232 | CNVD |
Autism | 22543975 | CNVD |
Obesity | 20622171 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:15033400-15036000 | Enhancers | Colon Smooth Muscle | Colon |
2 | chr17:15034800-15035400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr17:15035200-15035400 | Enhancers | K562 | blood |
4 | chr17:15035400-15036400 | Weak transcription | K562 | blood |
5 | chr17:15036400-15039000 | Enhancers | K562 | blood |
6 | chr17:15039000-15039600 | Weak transcription | K562 | blood |
7 | chr17:15039600-15039800 | Enhancers | K562 | blood |
8 | chr17:15048600-15049200 | Enhancers | Fetal Stomach | stomach |
9 | chr17:15050200-15050800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr17:15057600-15059000 | Enhancers | Primary monocytes fromperipheralblood | blood |
11 | chr17:15058000-15058800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
12 | chr17:15058000-15060800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
13 | chr17:15058000-15061200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
14 | chr17:15058200-15058600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
15 | chr17:15058200-15058800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr17:15058200-15058800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
17 | chr17:15058200-15059200 | Enhancers | Osteobl | bone |
18 | chr17:15058200-15059600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |